Articles/ Market Access/ Views and analysis ‘Free’ pricing in the UK: the influence of NICE and NHS England Leela Barham HTA, medicines cost effectiveness, NICE, Patient Access Scheme, pharma market access, pharma pricing, PPRS, UK drug pricing 0 Comment UK drug pricing: just how free is free pricing, these days? Share X ‘Free’ pricing in the UK: the influence of NICE and NHS England https://pharmaphorum.com/views-and-analysis/pas-free-pricing-uk-nice-nhs-england/
Articles/ Pharma Market Access/ Views and analysis Patient Access Schemes: a look behind the scenes Leela Barham Drug pricing, market access, NHS, NICE, PAS, Patient Access Scheme, patients 0 Comment Leela Barham takes a look behind the schemes for patient access in England and puts the case for Share X Patient Access Schemes: a look behind the scenes https://pharmaphorum.com/views-and-analysis/patient-access-schemes-a-look-behind-the-scenes/